Compare HLN & CBRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLN | CBRE |
|---|---|---|
| Founded | 2022 | 1906 |
| Country | United Kingdom | United States |
| Employees | N/A | 44000 |
| Industry | Package Goods/Cosmetics | Real Estate |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7B | 50.7B |
| IPO Year | N/A | 2001 |
| Metric | HLN | CBRE |
|---|---|---|
| Price | $10.07 | $132.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | N/A | ★ $177.86 |
| AVG Volume (30 Days) | ★ 8.3M | 2.0M |
| Earning Date | 02-26-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | N/A | ★ 22.61 |
| EPS | N/A | ★ 3.85 |
| Revenue | N/A | ★ $40,550,000,000.00 |
| Revenue This Year | $7.04 | $14.53 |
| Revenue Next Year | $4.58 | $9.05 |
| P/E Ratio | $49.05 | ★ $34.61 |
| Revenue Growth | N/A | ★ 13.37 |
| 52 Week Low | $8.71 | $108.45 |
| 52 Week High | $11.42 | $174.27 |
| Indicator | HLN | CBRE |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 32.75 |
| Support Level | $9.98 | $127.40 |
| Resistance Level | $10.31 | $136.89 |
| Average True Range (ATR) | 0.15 | 3.62 |
| MACD | -0.03 | 0.22 |
| Stochastic Oscillator | 14.30 | 19.13 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.